Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics

Author： Larach Daniel B   Cuchel Marina   Rader Daniel J  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.6, 2013-12, pp. : 635-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is high HDL cholesterol always good?

By Olsson Anders  

Annals of Medicine, Vol. 41, Iss. 1, 2009-01 ,pp. : 11-18

Informa Healthcare

Access to resources Recommend Favorite

Fatty liver and HDL-cholesterol: just a matter of quantity?

By Kantartzis Konstantinos   Hääring Hans-Ulrich   Stefan Norbert  

Future Lipidology, Vol. 3, Iss. 3, 2008-06 ,pp. : 225-227

Future Medicine

Access to resources Recommend Favorite

ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management*

By de Nijs Tjerk   Sniderman Allan   de Graaf Jacqueline  

Critical Reviews in Clinical Laboratory Sciences, Vol. 50, Iss. 6, 2013-11 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Investigational drugs targeting HDL-C metabolism and reverse cholesterol transport

By Robinson Jennifer G   Davidson Michael H  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 285-301

Future Medicine

Access to resources Recommend Favorite

Focus on the unprotective role of elevated HDL-C in unstable angina

By Sun Yuhua   Yang Yuejin  

Future Lipidology, Vol. 3, Iss. 2, 2008-04 ,pp. : 127-128

Future Medicine

Access to resources Recommend Favorite